本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cytek BioSciences

3.70
+0.05001.37%
盘后3.700.00000.00%16:33 EDT
成交量:100.10万
成交额:368.26万
市值:4.74亿
市盈率:-74.00
高:3.72
开:3.58
低:3.47
收:3.65
数据加载中...
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/09

重要事件披露

Form 8-K - Current report
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities